Global Gabapentin API Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gabapentin API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Gabapentin API Industry Forecast” looks at past sales and reviews total world Gabapentin API sales in 2023, providing a comprehensive analysis by region and market sector of projected Gabapentin API sales for 2024 through 2030. With Gabapentin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin API industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gabapentin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin API and breaks down the forecast by Purity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin API.
United States market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gabapentin API players cover IOL Chemicals and Pharmaceuticals, LGM Pharma, Metrochem API, Suanfarma, HRV Global, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Purity:
What is the 10-year outlook for the global Gabapentin API market?
What factors are driving Gabapentin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin API market opportunities vary by end market size?
How does Gabapentin API break out by Purity, by Application?
The global Gabapentin API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Gabapentin API Industry Forecast” looks at past sales and reviews total world Gabapentin API sales in 2023, providing a comprehensive analysis by region and market sector of projected Gabapentin API sales for 2024 through 2030. With Gabapentin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin API industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gabapentin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin API and breaks down the forecast by Purity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin API.
United States market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gabapentin API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gabapentin API players cover IOL Chemicals and Pharmaceuticals, LGM Pharma, Metrochem API, Suanfarma, HRV Global, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Purity:
- Below 98%
- Above 98%
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IOL Chemicals and Pharmaceuticals
- LGM Pharma
- Metrochem API
- Suanfarma
- HRV Global
- Zeon Pharma
- Amara Labs
- APIPL
- Aspen Biopharma
- Beloorbayir Biotech
- Divi's Laboratories
- Dongbang FTL
- Tosun Pharmaceutical
- Senwayer Century Chemical
- Wuhan Hengheda Pharm
What is the 10-year outlook for the global Gabapentin API market?
What factors are driving Gabapentin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin API market opportunities vary by end market size?
How does Gabapentin API break out by Purity, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gabapentin API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gabapentin API by Country/Region, 2019, 2023 & 2030
2.2 Gabapentin API Segment by Purity
2.2.1 Below 98%
2.2.2 Above 98%
2.3 Gabapentin API Sales by Purity
2.3.1 Global Gabapentin API Sales Market Share by Purity (2019-2024)
2.3.2 Global Gabapentin API Revenue and Market Share by Purity (2019-2024)
2.3.3 Global Gabapentin API Sale Price by Purity (2019-2024)
2.4 Gabapentin API Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin API Sales by Application
2.5.1 Global Gabapentin API Sale Market Share by Application (2019-2024)
2.5.2 Global Gabapentin API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gabapentin API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin API Breakdown Data by Company
3.1.1 Global Gabapentin API Annual Sales by Company (2019-2024)
3.1.2 Global Gabapentin API Sales Market Share by Company (2019-2024)
3.2 Global Gabapentin API Annual Revenue by Company (2019-2024)
3.2.1 Global Gabapentin API Revenue by Company (2019-2024)
3.2.2 Global Gabapentin API Revenue Market Share by Company (2019-2024)
3.3 Global Gabapentin API Sale Price by Company
3.4 Key Manufacturers Gabapentin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin API Product Location Distribution
3.4.2 Players Gabapentin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN API BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin API Market Size by Geographic Region (2019-2024)
4.1.1 Global Gabapentin API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gabapentin API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gabapentin API Market Size by Country/Region (2019-2024)
4.2.1 Global Gabapentin API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gabapentin API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gabapentin API Sales Growth
4.4 APAC Gabapentin API Sales Growth
4.5 Europe Gabapentin API Sales Growth
4.6 Middle East & Africa Gabapentin API Sales Growth
5 AMERICAS
5.1 Americas Gabapentin API Sales by Country
5.1.1 Americas Gabapentin API Sales by Country (2019-2024)
5.1.2 Americas Gabapentin API Revenue by Country (2019-2024)
5.2 Americas Gabapentin API Sales by Purity (2019-2024)
5.3 Americas Gabapentin API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin API Sales by Region
6.1.1 APAC Gabapentin API Sales by Region (2019-2024)
6.1.2 APAC Gabapentin API Revenue by Region (2019-2024)
6.2 APAC Gabapentin API Sales by Purity (2019-2024)
6.3 APAC Gabapentin API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin API by Country
7.1.1 Europe Gabapentin API Sales by Country (2019-2024)
7.1.2 Europe Gabapentin API Revenue by Country (2019-2024)
7.2 Europe Gabapentin API Sales by Purity (2019-2024)
7.3 Europe Gabapentin API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin API by Country
8.1.1 Middle East & Africa Gabapentin API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gabapentin API Revenue by Country (2019-2024)
8.2 Middle East & Africa Gabapentin API Sales by Purity (2019-2024)
8.3 Middle East & Africa Gabapentin API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin API
10.3 Manufacturing Process Analysis of Gabapentin API
10.4 Industry Chain Structure of Gabapentin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin API Distributors
11.3 Gabapentin API Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN API BY GEOGRAPHIC REGION
12.1 Global Gabapentin API Market Size Forecast by Region
12.1.1 Global Gabapentin API Forecast by Region (2025-2030)
12.1.2 Global Gabapentin API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Gabapentin API Forecast by Purity (2025-2030)
12.7 Global Gabapentin API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 IOL Chemicals and Pharmaceuticals
13.1.1 IOL Chemicals and Pharmaceuticals Company Information
13.1.2 IOL Chemicals and Pharmaceuticals Gabapentin API Product Portfolios and Specifications
13.1.3 IOL Chemicals and Pharmaceuticals Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 IOL Chemicals and Pharmaceuticals Main Business Overview
13.1.5 IOL Chemicals and Pharmaceuticals Latest Developments
13.2 LGM Pharma
13.2.1 LGM Pharma Company Information
13.2.2 LGM Pharma Gabapentin API Product Portfolios and Specifications
13.2.3 LGM Pharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 LGM Pharma Main Business Overview
13.2.5 LGM Pharma Latest Developments
13.3 Metrochem API
13.3.1 Metrochem API Company Information
13.3.2 Metrochem API Gabapentin API Product Portfolios and Specifications
13.3.3 Metrochem API Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Metrochem API Main Business Overview
13.3.5 Metrochem API Latest Developments
13.4 Suanfarma
13.4.1 Suanfarma Company Information
13.4.2 Suanfarma Gabapentin API Product Portfolios and Specifications
13.4.3 Suanfarma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Suanfarma Main Business Overview
13.4.5 Suanfarma Latest Developments
13.5 HRV Global
13.5.1 HRV Global Company Information
13.5.2 HRV Global Gabapentin API Product Portfolios and Specifications
13.5.3 HRV Global Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 HRV Global Main Business Overview
13.5.5 HRV Global Latest Developments
13.6 Zeon Pharma
13.6.1 Zeon Pharma Company Information
13.6.2 Zeon Pharma Gabapentin API Product Portfolios and Specifications
13.6.3 Zeon Pharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zeon Pharma Main Business Overview
13.6.5 Zeon Pharma Latest Developments
13.7 Amara Labs
13.7.1 Amara Labs Company Information
13.7.2 Amara Labs Gabapentin API Product Portfolios and Specifications
13.7.3 Amara Labs Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Amara Labs Main Business Overview
13.7.5 Amara Labs Latest Developments
13.8 APIPL
13.8.1 APIPL Company Information
13.8.2 APIPL Gabapentin API Product Portfolios and Specifications
13.8.3 APIPL Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 APIPL Main Business Overview
13.8.5 APIPL Latest Developments
13.9 Aspen Biopharma
13.9.1 Aspen Biopharma Company Information
13.9.2 Aspen Biopharma Gabapentin API Product Portfolios and Specifications
13.9.3 Aspen Biopharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aspen Biopharma Main Business Overview
13.9.5 Aspen Biopharma Latest Developments
13.10 Beloorbayir Biotech
13.10.1 Beloorbayir Biotech Company Information
13.10.2 Beloorbayir Biotech Gabapentin API Product Portfolios and Specifications
13.10.3 Beloorbayir Biotech Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Beloorbayir Biotech Main Business Overview
13.10.5 Beloorbayir Biotech Latest Developments
13.11 Divi's Laboratories
13.11.1 Divi's Laboratories Company Information
13.11.2 Divi's Laboratories Gabapentin API Product Portfolios and Specifications
13.11.3 Divi's Laboratories Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Divi's Laboratories Main Business Overview
13.11.5 Divi's Laboratories Latest Developments
13.12 Dongbang FTL
13.12.1 Dongbang FTL Company Information
13.12.2 Dongbang FTL Gabapentin API Product Portfolios and Specifications
13.12.3 Dongbang FTL Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Dongbang FTL Main Business Overview
13.12.5 Dongbang FTL Latest Developments
13.13 Tosun Pharmaceutical
13.13.1 Tosun Pharmaceutical Company Information
13.13.2 Tosun Pharmaceutical Gabapentin API Product Portfolios and Specifications
13.13.3 Tosun Pharmaceutical Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Tosun Pharmaceutical Main Business Overview
13.13.5 Tosun Pharmaceutical Latest Developments
13.14 Senwayer Century Chemical
13.14.1 Senwayer Century Chemical Company Information
13.14.2 Senwayer Century Chemical Gabapentin API Product Portfolios and Specifications
13.14.3 Senwayer Century Chemical Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Senwayer Century Chemical Main Business Overview
13.14.5 Senwayer Century Chemical Latest Developments
13.15 Wuhan Hengheda Pharm
13.15.1 Wuhan Hengheda Pharm Company Information
13.15.2 Wuhan Hengheda Pharm Gabapentin API Product Portfolios and Specifications
13.15.3 Wuhan Hengheda Pharm Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Wuhan Hengheda Pharm Main Business Overview
13.15.5 Wuhan Hengheda Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Gabapentin API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Gabapentin API by Country/Region, 2019, 2023 & 2030
2.2 Gabapentin API Segment by Purity
2.2.1 Below 98%
2.2.2 Above 98%
2.3 Gabapentin API Sales by Purity
2.3.1 Global Gabapentin API Sales Market Share by Purity (2019-2024)
2.3.2 Global Gabapentin API Revenue and Market Share by Purity (2019-2024)
2.3.3 Global Gabapentin API Sale Price by Purity (2019-2024)
2.4 Gabapentin API Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin API Sales by Application
2.5.1 Global Gabapentin API Sale Market Share by Application (2019-2024)
2.5.2 Global Gabapentin API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Gabapentin API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin API Breakdown Data by Company
3.1.1 Global Gabapentin API Annual Sales by Company (2019-2024)
3.1.2 Global Gabapentin API Sales Market Share by Company (2019-2024)
3.2 Global Gabapentin API Annual Revenue by Company (2019-2024)
3.2.1 Global Gabapentin API Revenue by Company (2019-2024)
3.2.2 Global Gabapentin API Revenue Market Share by Company (2019-2024)
3.3 Global Gabapentin API Sale Price by Company
3.4 Key Manufacturers Gabapentin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin API Product Location Distribution
3.4.2 Players Gabapentin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN API BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin API Market Size by Geographic Region (2019-2024)
4.1.1 Global Gabapentin API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Gabapentin API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Gabapentin API Market Size by Country/Region (2019-2024)
4.2.1 Global Gabapentin API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Gabapentin API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gabapentin API Sales Growth
4.4 APAC Gabapentin API Sales Growth
4.5 Europe Gabapentin API Sales Growth
4.6 Middle East & Africa Gabapentin API Sales Growth
5 AMERICAS
5.1 Americas Gabapentin API Sales by Country
5.1.1 Americas Gabapentin API Sales by Country (2019-2024)
5.1.2 Americas Gabapentin API Revenue by Country (2019-2024)
5.2 Americas Gabapentin API Sales by Purity (2019-2024)
5.3 Americas Gabapentin API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin API Sales by Region
6.1.1 APAC Gabapentin API Sales by Region (2019-2024)
6.1.2 APAC Gabapentin API Revenue by Region (2019-2024)
6.2 APAC Gabapentin API Sales by Purity (2019-2024)
6.3 APAC Gabapentin API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin API by Country
7.1.1 Europe Gabapentin API Sales by Country (2019-2024)
7.1.2 Europe Gabapentin API Revenue by Country (2019-2024)
7.2 Europe Gabapentin API Sales by Purity (2019-2024)
7.3 Europe Gabapentin API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin API by Country
8.1.1 Middle East & Africa Gabapentin API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Gabapentin API Revenue by Country (2019-2024)
8.2 Middle East & Africa Gabapentin API Sales by Purity (2019-2024)
8.3 Middle East & Africa Gabapentin API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin API
10.3 Manufacturing Process Analysis of Gabapentin API
10.4 Industry Chain Structure of Gabapentin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin API Distributors
11.3 Gabapentin API Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN API BY GEOGRAPHIC REGION
12.1 Global Gabapentin API Market Size Forecast by Region
12.1.1 Global Gabapentin API Forecast by Region (2025-2030)
12.1.2 Global Gabapentin API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Gabapentin API Forecast by Purity (2025-2030)
12.7 Global Gabapentin API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 IOL Chemicals and Pharmaceuticals
13.1.1 IOL Chemicals and Pharmaceuticals Company Information
13.1.2 IOL Chemicals and Pharmaceuticals Gabapentin API Product Portfolios and Specifications
13.1.3 IOL Chemicals and Pharmaceuticals Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 IOL Chemicals and Pharmaceuticals Main Business Overview
13.1.5 IOL Chemicals and Pharmaceuticals Latest Developments
13.2 LGM Pharma
13.2.1 LGM Pharma Company Information
13.2.2 LGM Pharma Gabapentin API Product Portfolios and Specifications
13.2.3 LGM Pharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 LGM Pharma Main Business Overview
13.2.5 LGM Pharma Latest Developments
13.3 Metrochem API
13.3.1 Metrochem API Company Information
13.3.2 Metrochem API Gabapentin API Product Portfolios and Specifications
13.3.3 Metrochem API Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Metrochem API Main Business Overview
13.3.5 Metrochem API Latest Developments
13.4 Suanfarma
13.4.1 Suanfarma Company Information
13.4.2 Suanfarma Gabapentin API Product Portfolios and Specifications
13.4.3 Suanfarma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Suanfarma Main Business Overview
13.4.5 Suanfarma Latest Developments
13.5 HRV Global
13.5.1 HRV Global Company Information
13.5.2 HRV Global Gabapentin API Product Portfolios and Specifications
13.5.3 HRV Global Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 HRV Global Main Business Overview
13.5.5 HRV Global Latest Developments
13.6 Zeon Pharma
13.6.1 Zeon Pharma Company Information
13.6.2 Zeon Pharma Gabapentin API Product Portfolios and Specifications
13.6.3 Zeon Pharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zeon Pharma Main Business Overview
13.6.5 Zeon Pharma Latest Developments
13.7 Amara Labs
13.7.1 Amara Labs Company Information
13.7.2 Amara Labs Gabapentin API Product Portfolios and Specifications
13.7.3 Amara Labs Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Amara Labs Main Business Overview
13.7.5 Amara Labs Latest Developments
13.8 APIPL
13.8.1 APIPL Company Information
13.8.2 APIPL Gabapentin API Product Portfolios and Specifications
13.8.3 APIPL Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 APIPL Main Business Overview
13.8.5 APIPL Latest Developments
13.9 Aspen Biopharma
13.9.1 Aspen Biopharma Company Information
13.9.2 Aspen Biopharma Gabapentin API Product Portfolios and Specifications
13.9.3 Aspen Biopharma Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aspen Biopharma Main Business Overview
13.9.5 Aspen Biopharma Latest Developments
13.10 Beloorbayir Biotech
13.10.1 Beloorbayir Biotech Company Information
13.10.2 Beloorbayir Biotech Gabapentin API Product Portfolios and Specifications
13.10.3 Beloorbayir Biotech Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Beloorbayir Biotech Main Business Overview
13.10.5 Beloorbayir Biotech Latest Developments
13.11 Divi's Laboratories
13.11.1 Divi's Laboratories Company Information
13.11.2 Divi's Laboratories Gabapentin API Product Portfolios and Specifications
13.11.3 Divi's Laboratories Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Divi's Laboratories Main Business Overview
13.11.5 Divi's Laboratories Latest Developments
13.12 Dongbang FTL
13.12.1 Dongbang FTL Company Information
13.12.2 Dongbang FTL Gabapentin API Product Portfolios and Specifications
13.12.3 Dongbang FTL Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Dongbang FTL Main Business Overview
13.12.5 Dongbang FTL Latest Developments
13.13 Tosun Pharmaceutical
13.13.1 Tosun Pharmaceutical Company Information
13.13.2 Tosun Pharmaceutical Gabapentin API Product Portfolios and Specifications
13.13.3 Tosun Pharmaceutical Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Tosun Pharmaceutical Main Business Overview
13.13.5 Tosun Pharmaceutical Latest Developments
13.14 Senwayer Century Chemical
13.14.1 Senwayer Century Chemical Company Information
13.14.2 Senwayer Century Chemical Gabapentin API Product Portfolios and Specifications
13.14.3 Senwayer Century Chemical Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Senwayer Century Chemical Main Business Overview
13.14.5 Senwayer Century Chemical Latest Developments
13.15 Wuhan Hengheda Pharm
13.15.1 Wuhan Hengheda Pharm Company Information
13.15.2 Wuhan Hengheda Pharm Gabapentin API Product Portfolios and Specifications
13.15.3 Wuhan Hengheda Pharm Gabapentin API Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Wuhan Hengheda Pharm Main Business Overview
13.15.5 Wuhan Hengheda Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gabapentin API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gabapentin API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Below 98%
Table 4. Major Players of Above 98%
Table 5. Global Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 6. Global Gabapentin API Sales Market Share by Purity (2019-2024)
Table 7. Global Gabapentin API Revenue by Purity (2019-2024) & ($ million)
Table 8. Global Gabapentin API Revenue Market Share by Purity (2019-2024)
Table 9. Global Gabapentin API Sale Price by Purity (2019-2024) & (US$/Ton)
Table 10. Global Gabapentin API Sale by Application (2019-2024) & (Tons)
Table 11. Global Gabapentin API Sale Market Share by Application (2019-2024)
Table 12. Global Gabapentin API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Gabapentin API Revenue Market Share by Application (2019-2024)
Table 14. Global Gabapentin API Sale Price by Application (2019-2024) & (US$/Ton)
Table 15. Global Gabapentin API Sales by Company (2019-2024) & (Tons)
Table 16. Global Gabapentin API Sales Market Share by Company (2019-2024)
Table 17. Global Gabapentin API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Gabapentin API Revenue Market Share by Company (2019-2024)
Table 19. Global Gabapentin API Sale Price by Company (2019-2024) & (US$/Ton)
Table 20. Key Manufacturers Gabapentin API Producing Area Distribution and Sales Area
Table 21. Players Gabapentin API Products Offered
Table 22. Gabapentin API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Gabapentin API Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Gabapentin API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Gabapentin API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Gabapentin API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Gabapentin API Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Gabapentin API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Gabapentin API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Gabapentin API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 34. Americas Gabapentin API Sales Market Share by Country (2019-2024)
Table 35. Americas Gabapentin API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 37. Americas Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 38. APAC Gabapentin API Sales by Region (2019-2024) & (Tons)
Table 39. APAC Gabapentin API Sales Market Share by Region (2019-2024)
Table 40. APAC Gabapentin API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 42. APAC Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 43. Europe Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 44. Europe Gabapentin API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 46. Europe Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Gabapentin API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 50. Middle East & Africa Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Gabapentin API
Table 52. Key Market Challenges & Risks of Gabapentin API
Table 53. Key Industry Trends of Gabapentin API
Table 54. Gabapentin API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Gabapentin API Distributors List
Table 57. Gabapentin API Customer List
Table 58. Global Gabapentin API Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Gabapentin API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Gabapentin API Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Gabapentin API Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Gabapentin API Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Gabapentin API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Gabapentin API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Gabapentin API Sales Forecast by Purity (2025-2030) & (Tons)
Table 69. Global Gabapentin API Revenue Forecast by Purity (2025-2030) & ($ millions)
Table 70. Global Gabapentin API Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Gabapentin API Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. IOL Chemicals and Pharmaceuticals Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 73. IOL Chemicals and Pharmaceuticals Gabapentin API Product Portfolios and Specifications
Table 74. IOL Chemicals and Pharmaceuticals Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. IOL Chemicals and Pharmaceuticals Main Business
Table 76. IOL Chemicals and Pharmaceuticals Latest Developments
Table 77. LGM Pharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 78. LGM Pharma Gabapentin API Product Portfolios and Specifications
Table 79. LGM Pharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. LGM Pharma Main Business
Table 81. LGM Pharma Latest Developments
Table 82. Metrochem API Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 83. Metrochem API Gabapentin API Product Portfolios and Specifications
Table 84. Metrochem API Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Metrochem API Main Business
Table 86. Metrochem API Latest Developments
Table 87. Suanfarma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 88. Suanfarma Gabapentin API Product Portfolios and Specifications
Table 89. Suanfarma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Suanfarma Main Business
Table 91. Suanfarma Latest Developments
Table 92. HRV Global Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 93. HRV Global Gabapentin API Product Portfolios and Specifications
Table 94. HRV Global Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. HRV Global Main Business
Table 96. HRV Global Latest Developments
Table 97. Zeon Pharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 98. Zeon Pharma Gabapentin API Product Portfolios and Specifications
Table 99. Zeon Pharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Zeon Pharma Main Business
Table 101. Zeon Pharma Latest Developments
Table 102. Amara Labs Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 103. Amara Labs Gabapentin API Product Portfolios and Specifications
Table 104. Amara Labs Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Amara Labs Main Business
Table 106. Amara Labs Latest Developments
Table 107. APIPL Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 108. APIPL Gabapentin API Product Portfolios and Specifications
Table 109. APIPL Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. APIPL Main Business
Table 111. APIPL Latest Developments
Table 112. Aspen Biopharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 113. Aspen Biopharma Gabapentin API Product Portfolios and Specifications
Table 114. Aspen Biopharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Aspen Biopharma Main Business
Table 116. Aspen Biopharma Latest Developments
Table 117. Beloorbayir Biotech Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 118. Beloorbayir Biotech Gabapentin API Product Portfolios and Specifications
Table 119. Beloorbayir Biotech Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. Beloorbayir Biotech Main Business
Table 121. Beloorbayir Biotech Latest Developments
Table 122. Divi's Laboratories Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 123. Divi's Laboratories Gabapentin API Product Portfolios and Specifications
Table 124. Divi's Laboratories Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. Divi's Laboratories Main Business
Table 126. Divi's Laboratories Latest Developments
Table 127. Dongbang FTL Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 128. Dongbang FTL Gabapentin API Product Portfolios and Specifications
Table 129. Dongbang FTL Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. Dongbang FTL Main Business
Table 131. Dongbang FTL Latest Developments
Table 132. Tosun Pharmaceutical Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 133. Tosun Pharmaceutical Gabapentin API Product Portfolios and Specifications
Table 134. Tosun Pharmaceutical Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 135. Tosun Pharmaceutical Main Business
Table 136. Tosun Pharmaceutical Latest Developments
Table 137. Senwayer Century Chemical Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 138. Senwayer Century Chemical Gabapentin API Product Portfolios and Specifications
Table 139. Senwayer Century Chemical Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 140. Senwayer Century Chemical Main Business
Table 141. Senwayer Century Chemical Latest Developments
Table 142. Wuhan Hengheda Pharm Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 143. Wuhan Hengheda Pharm Gabapentin API Product Portfolios and Specifications
Table 144. Wuhan Hengheda Pharm Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 145. Wuhan Hengheda Pharm Main Business
Table 146. Wuhan Hengheda Pharm Latest Developments
Table 1. Gabapentin API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Gabapentin API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Below 98%
Table 4. Major Players of Above 98%
Table 5. Global Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 6. Global Gabapentin API Sales Market Share by Purity (2019-2024)
Table 7. Global Gabapentin API Revenue by Purity (2019-2024) & ($ million)
Table 8. Global Gabapentin API Revenue Market Share by Purity (2019-2024)
Table 9. Global Gabapentin API Sale Price by Purity (2019-2024) & (US$/Ton)
Table 10. Global Gabapentin API Sale by Application (2019-2024) & (Tons)
Table 11. Global Gabapentin API Sale Market Share by Application (2019-2024)
Table 12. Global Gabapentin API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Gabapentin API Revenue Market Share by Application (2019-2024)
Table 14. Global Gabapentin API Sale Price by Application (2019-2024) & (US$/Ton)
Table 15. Global Gabapentin API Sales by Company (2019-2024) & (Tons)
Table 16. Global Gabapentin API Sales Market Share by Company (2019-2024)
Table 17. Global Gabapentin API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Gabapentin API Revenue Market Share by Company (2019-2024)
Table 19. Global Gabapentin API Sale Price by Company (2019-2024) & (US$/Ton)
Table 20. Key Manufacturers Gabapentin API Producing Area Distribution and Sales Area
Table 21. Players Gabapentin API Products Offered
Table 22. Gabapentin API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Gabapentin API Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Gabapentin API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Gabapentin API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Gabapentin API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Gabapentin API Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Gabapentin API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Gabapentin API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Gabapentin API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 34. Americas Gabapentin API Sales Market Share by Country (2019-2024)
Table 35. Americas Gabapentin API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 37. Americas Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 38. APAC Gabapentin API Sales by Region (2019-2024) & (Tons)
Table 39. APAC Gabapentin API Sales Market Share by Region (2019-2024)
Table 40. APAC Gabapentin API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 42. APAC Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 43. Europe Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 44. Europe Gabapentin API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 46. Europe Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Gabapentin API Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Gabapentin API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Gabapentin API Sales by Purity (2019-2024) & (Tons)
Table 50. Middle East & Africa Gabapentin API Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Gabapentin API
Table 52. Key Market Challenges & Risks of Gabapentin API
Table 53. Key Industry Trends of Gabapentin API
Table 54. Gabapentin API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Gabapentin API Distributors List
Table 57. Gabapentin API Customer List
Table 58. Global Gabapentin API Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Gabapentin API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Gabapentin API Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Gabapentin API Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Gabapentin API Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Gabapentin API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Gabapentin API Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Gabapentin API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Gabapentin API Sales Forecast by Purity (2025-2030) & (Tons)
Table 69. Global Gabapentin API Revenue Forecast by Purity (2025-2030) & ($ millions)
Table 70. Global Gabapentin API Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Gabapentin API Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. IOL Chemicals and Pharmaceuticals Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 73. IOL Chemicals and Pharmaceuticals Gabapentin API Product Portfolios and Specifications
Table 74. IOL Chemicals and Pharmaceuticals Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. IOL Chemicals and Pharmaceuticals Main Business
Table 76. IOL Chemicals and Pharmaceuticals Latest Developments
Table 77. LGM Pharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 78. LGM Pharma Gabapentin API Product Portfolios and Specifications
Table 79. LGM Pharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. LGM Pharma Main Business
Table 81. LGM Pharma Latest Developments
Table 82. Metrochem API Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 83. Metrochem API Gabapentin API Product Portfolios and Specifications
Table 84. Metrochem API Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Metrochem API Main Business
Table 86. Metrochem API Latest Developments
Table 87. Suanfarma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 88. Suanfarma Gabapentin API Product Portfolios and Specifications
Table 89. Suanfarma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Suanfarma Main Business
Table 91. Suanfarma Latest Developments
Table 92. HRV Global Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 93. HRV Global Gabapentin API Product Portfolios and Specifications
Table 94. HRV Global Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. HRV Global Main Business
Table 96. HRV Global Latest Developments
Table 97. Zeon Pharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 98. Zeon Pharma Gabapentin API Product Portfolios and Specifications
Table 99. Zeon Pharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Zeon Pharma Main Business
Table 101. Zeon Pharma Latest Developments
Table 102. Amara Labs Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 103. Amara Labs Gabapentin API Product Portfolios and Specifications
Table 104. Amara Labs Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Amara Labs Main Business
Table 106. Amara Labs Latest Developments
Table 107. APIPL Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 108. APIPL Gabapentin API Product Portfolios and Specifications
Table 109. APIPL Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. APIPL Main Business
Table 111. APIPL Latest Developments
Table 112. Aspen Biopharma Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 113. Aspen Biopharma Gabapentin API Product Portfolios and Specifications
Table 114. Aspen Biopharma Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Aspen Biopharma Main Business
Table 116. Aspen Biopharma Latest Developments
Table 117. Beloorbayir Biotech Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 118. Beloorbayir Biotech Gabapentin API Product Portfolios and Specifications
Table 119. Beloorbayir Biotech Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. Beloorbayir Biotech Main Business
Table 121. Beloorbayir Biotech Latest Developments
Table 122. Divi's Laboratories Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 123. Divi's Laboratories Gabapentin API Product Portfolios and Specifications
Table 124. Divi's Laboratories Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. Divi's Laboratories Main Business
Table 126. Divi's Laboratories Latest Developments
Table 127. Dongbang FTL Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 128. Dongbang FTL Gabapentin API Product Portfolios and Specifications
Table 129. Dongbang FTL Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. Dongbang FTL Main Business
Table 131. Dongbang FTL Latest Developments
Table 132. Tosun Pharmaceutical Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 133. Tosun Pharmaceutical Gabapentin API Product Portfolios and Specifications
Table 134. Tosun Pharmaceutical Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 135. Tosun Pharmaceutical Main Business
Table 136. Tosun Pharmaceutical Latest Developments
Table 137. Senwayer Century Chemical Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 138. Senwayer Century Chemical Gabapentin API Product Portfolios and Specifications
Table 139. Senwayer Century Chemical Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 140. Senwayer Century Chemical Main Business
Table 141. Senwayer Century Chemical Latest Developments
Table 142. Wuhan Hengheda Pharm Basic Information, Gabapentin API Manufacturing Base, Sales Area and Its Competitors
Table 143. Wuhan Hengheda Pharm Gabapentin API Product Portfolios and Specifications
Table 144. Wuhan Hengheda Pharm Gabapentin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 145. Wuhan Hengheda Pharm Main Business
Table 146. Wuhan Hengheda Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gabapentin API
Figure 2. Gabapentin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin API Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Gabapentin API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Gabapentin API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Gabapentin API Sales Market Share by Country/Region (2023)
Figure 10. Gabapentin API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Below 98%
Figure 12. Product Picture of Above 98%
Figure 13. Global Gabapentin API Sales Market Share by Purity in 2023
Figure 14. Global Gabapentin API Revenue Market Share by Purity (2019-2024)
Figure 15. Gabapentin API Consumed in Epilepsy
Figure 16. Global Gabapentin API Market: Epilepsy (2019-2024) & (Tons)
Figure 17. Gabapentin API Consumed in Neuropathic Pain
Figure 18. Global Gabapentin API Market: Neuropathic Pain (2019-2024) & (Tons)
Figure 19. Gabapentin API Consumed in Restless Legs Syndrome
Figure 20. Global Gabapentin API Market: Restless Legs Syndrome (2019-2024) & (Tons)
Figure 21. Gabapentin API Consumed in Others
Figure 22. Global Gabapentin API Market: Others (2019-2024) & (Tons)
Figure 23. Global Gabapentin API Sale Market Share by Application (2023)
Figure 24. Global Gabapentin API Revenue Market Share by Application in 2023
Figure 25. Gabapentin API Sales by Company in 2023 (Tons)
Figure 26. Global Gabapentin API Sales Market Share by Company in 2023
Figure 27. Gabapentin API Revenue by Company in 2023 ($ millions)
Figure 28. Global Gabapentin API Revenue Market Share by Company in 2023
Figure 29. Global Gabapentin API Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Gabapentin API Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Gabapentin API Sales 2019-2024 (Tons)
Figure 32. Americas Gabapentin API Revenue 2019-2024 ($ millions)
Figure 33. APAC Gabapentin API Sales 2019-2024 (Tons)
Figure 34. APAC Gabapentin API Revenue 2019-2024 ($ millions)
Figure 35. Europe Gabapentin API Sales 2019-2024 (Tons)
Figure 36. Europe Gabapentin API Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Gabapentin API Sales 2019-2024 (Tons)
Figure 38. Middle East & Africa Gabapentin API Revenue 2019-2024 ($ millions)
Figure 39. Americas Gabapentin API Sales Market Share by Country in 2023
Figure 40. Americas Gabapentin API Revenue Market Share by Country (2019-2024)
Figure 41. Americas Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 42. Americas Gabapentin API Sales Market Share by Application (2019-2024)
Figure 43. United States Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Gabapentin API Sales Market Share by Region in 2023
Figure 48. APAC Gabapentin API Revenue Market Share by Region (2019-2024)
Figure 49. APAC Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 50. APAC Gabapentin API Sales Market Share by Application (2019-2024)
Figure 51. China Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 55. India Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Gabapentin API Sales Market Share by Country in 2023
Figure 59. Europe Gabapentin API Revenue Market Share by Country (2019-2024)
Figure 60. Europe Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 61. Europe Gabapentin API Sales Market Share by Application (2019-2024)
Figure 62. Germany Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 63. France Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Gabapentin API Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 69. Middle East & Africa Gabapentin API Sales Market Share by Application (2019-2024)
Figure 70. Egypt Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Gabapentin API in 2023
Figure 76. Manufacturing Process Analysis of Gabapentin API
Figure 77. Industry Chain Structure of Gabapentin API
Figure 78. Channels of Distribution
Figure 79. Global Gabapentin API Sales Market Forecast by Region (2025-2030)
Figure 80. Global Gabapentin API Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Gabapentin API Sales Market Share Forecast by Purity (2025-2030)
Figure 82. Global Gabapentin API Revenue Market Share Forecast by Purity (2025-2030)
Figure 83. Global Gabapentin API Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Gabapentin API Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Gabapentin API
Figure 2. Gabapentin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin API Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Gabapentin API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Gabapentin API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Gabapentin API Sales Market Share by Country/Region (2023)
Figure 10. Gabapentin API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Below 98%
Figure 12. Product Picture of Above 98%
Figure 13. Global Gabapentin API Sales Market Share by Purity in 2023
Figure 14. Global Gabapentin API Revenue Market Share by Purity (2019-2024)
Figure 15. Gabapentin API Consumed in Epilepsy
Figure 16. Global Gabapentin API Market: Epilepsy (2019-2024) & (Tons)
Figure 17. Gabapentin API Consumed in Neuropathic Pain
Figure 18. Global Gabapentin API Market: Neuropathic Pain (2019-2024) & (Tons)
Figure 19. Gabapentin API Consumed in Restless Legs Syndrome
Figure 20. Global Gabapentin API Market: Restless Legs Syndrome (2019-2024) & (Tons)
Figure 21. Gabapentin API Consumed in Others
Figure 22. Global Gabapentin API Market: Others (2019-2024) & (Tons)
Figure 23. Global Gabapentin API Sale Market Share by Application (2023)
Figure 24. Global Gabapentin API Revenue Market Share by Application in 2023
Figure 25. Gabapentin API Sales by Company in 2023 (Tons)
Figure 26. Global Gabapentin API Sales Market Share by Company in 2023
Figure 27. Gabapentin API Revenue by Company in 2023 ($ millions)
Figure 28. Global Gabapentin API Revenue Market Share by Company in 2023
Figure 29. Global Gabapentin API Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Gabapentin API Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Gabapentin API Sales 2019-2024 (Tons)
Figure 32. Americas Gabapentin API Revenue 2019-2024 ($ millions)
Figure 33. APAC Gabapentin API Sales 2019-2024 (Tons)
Figure 34. APAC Gabapentin API Revenue 2019-2024 ($ millions)
Figure 35. Europe Gabapentin API Sales 2019-2024 (Tons)
Figure 36. Europe Gabapentin API Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Gabapentin API Sales 2019-2024 (Tons)
Figure 38. Middle East & Africa Gabapentin API Revenue 2019-2024 ($ millions)
Figure 39. Americas Gabapentin API Sales Market Share by Country in 2023
Figure 40. Americas Gabapentin API Revenue Market Share by Country (2019-2024)
Figure 41. Americas Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 42. Americas Gabapentin API Sales Market Share by Application (2019-2024)
Figure 43. United States Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Gabapentin API Sales Market Share by Region in 2023
Figure 48. APAC Gabapentin API Revenue Market Share by Region (2019-2024)
Figure 49. APAC Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 50. APAC Gabapentin API Sales Market Share by Application (2019-2024)
Figure 51. China Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 55. India Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Gabapentin API Sales Market Share by Country in 2023
Figure 59. Europe Gabapentin API Revenue Market Share by Country (2019-2024)
Figure 60. Europe Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 61. Europe Gabapentin API Sales Market Share by Application (2019-2024)
Figure 62. Germany Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 63. France Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Gabapentin API Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Gabapentin API Sales Market Share by Purity (2019-2024)
Figure 69. Middle East & Africa Gabapentin API Sales Market Share by Application (2019-2024)
Figure 70. Egypt Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Gabapentin API Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Gabapentin API in 2023
Figure 76. Manufacturing Process Analysis of Gabapentin API
Figure 77. Industry Chain Structure of Gabapentin API
Figure 78. Channels of Distribution
Figure 79. Global Gabapentin API Sales Market Forecast by Region (2025-2030)
Figure 80. Global Gabapentin API Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Gabapentin API Sales Market Share Forecast by Purity (2025-2030)
Figure 82. Global Gabapentin API Revenue Market Share Forecast by Purity (2025-2030)
Figure 83. Global Gabapentin API Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Gabapentin API Revenue Market Share Forecast by Application (2025-2030)
